Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis

Enferm Infecc Microbiol Clin (Engl Ed). 2018 Feb;36(2):142-143. doi: 10.1016/j.eimc.2017.04.009. Epub 2017 Jun 7.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Arthroplasty, Replacement, Knee*
  • Device Removal
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Gentamicins / therapeutic use
  • Humans
  • Knee Prosthesis / adverse effects*
  • Middle Aged
  • Oxacillin / pharmacology
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / microbiology
  • Renal Insufficiency, Chronic / complications
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / etiology
  • Staphylococcal Infections / microbiology
  • Staphylococcus epidermidis / drug effects*
  • Staphylococcus epidermidis / isolation & purification
  • Teicoplanin / administration & dosage
  • Teicoplanin / analogs & derivatives*
  • Teicoplanin / pharmacology
  • Teicoplanin / therapeutic use
  • Time Factors
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Teicoplanin
  • Vancomycin
  • dalbavancin
  • Oxacillin